Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alexion Pharmaceuticals (NQ: ALXN)
122.26 USD  +1.44 (+1.19%)
Streaming Delayed Price  /  Updated: 2:16 PM EDT, Jul 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 572,523
Open 120.72
Bid (Size) 122.23 (2)
Ask (Size) 122.29 (1)
Prev. Close 120.82
Today's Range 120.59 - 122.75
52wk Range 92.56 - 141.86
Shares Outstanding 222,500,663
Dividend Yield N/A
Performance
YTD
+24.69%
+24.69%
1 Month
+3.67%
+3.67%
3 Month
-11.08%
-11.08%
6 Month
+13.65%
+13.65%
1 Year
-9.15%
-9.15%
Top News
More News
Alexion to Report Second Quarter 2019 Results On Wednesday, July 24, 2019
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the Company will report its financial results for the second quarter ended June 30, 2019 before the US financial markets open on July 24,... Read More
from Business Wire News Releases
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Read More
from Business Wire News Releases
More News
Read More
ADDING MULTIMEDIA Alexion Receives FDA Approval of SOLIRIS® (eculizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) who are Anti-Aquaporin-4 (AQP4) Antibody Positi
from Business Wire News Releases
A Peek Into The Markets: US Stock Futures Down; All Eyes On Jobs Report
category SENS , Markets , Pre/Market Outlook , and 12 more.
from Benzinga
5 Stocks To Watch For July 5, 2019
category WPP , AVGO , Benzinga , and 12 more.
from Benzinga
3 Biotech Stocks That Could Double Your Money
category Market News , APLS , DVAX , and 2 more.
from Motley Fool
3 Top Biotech Stocks to Buy for the 2nd Half of 2019
category Market News , CARA , VRTX , and 1 more.
from Motley Fool
Pfizer gene therapy for rare muscle disease shows promise in small, early study
category companyNews
from Reuters: Company News
Stock Upgrades: Alexion Pharmaceuticals Shows Rising Relative Strength
from Investor's Business Daily
Alexion Confirms FDA Approval For Soliris
category FDA , News , ALXN , and 2 more.
from Benzinga
How to Invest in Biotech Stocks
category ALXN , XBI , VRTX , and 3 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X